BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 32641120)

  • 21. Hereditary hemochromatosis in north-eastern Romania.
    Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.
    Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mutations in the HFE gene (C282Y, H63D, S65C) in alcoholic patients with finding of iron overload].
    Campos Franco J; González Quintela A; Fernández de Trocóniz LL; Barros Angueira F; Pérez-Quintela BV; Pérez Becerra E; Martínez de Rituerto ST; Otero Antón E; Torre Carballada JA
    Rev Clin Esp; 2002 Oct; 202(10):534-9. PubMed ID: 12361551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p.H63D allele of the HFE gene protects against low iron stores in Sri Lanka.
    Allen A; Premawardhena A; Allen S; Rodrigo R; Manamperi A; Perera L; Wray K; Armitage A; Fisher C; Drakesmith A; Robson K; Weatherall D
    Blood Cells Mol Dis; 2019 May; 76():72-77. PubMed ID: 30827762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.
    Beutler E; Felitti V; Gelbart T; Ho N
    Ann Intern Med; 2000 Sep; 133(5):329-37. PubMed ID: 10979877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
    Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
    Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HFE Gene Mutations and Iron Status in 100 Healthy Polish Children.
    Kaczorowska-Hac B; Luszczyk M; Antosiewicz J; Ziolkowski W; Adamkiewicz-Drozynska E; Mysliwiec M; Milosz E; Kaczor JJ
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e240-e243. PubMed ID: 28406842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.
    Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M
    Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
    Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
    J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of
    Singal M; Mahmoud A; Phatak PD
    Expert Rev Hematol; 2024; 17(4-5):145-152. PubMed ID: 38551816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Iron intake and HFE gen in male adults from Buenos Aires].
    Felipoff AL; Fleischman SJ; Donadío ML; Sebastiano V; Castro M; Vellicce A; Rey JA; Lardo MM; Langini SH
    Medicina (B Aires); 2017; 77(6):458-464. PubMed ID: 29223935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
    Aguilar-Martinez P; Grandchamp B; Cunat S; Cadet E; Blanc F; Nourrit M; Lassoued K; Schved JF; Rochette J
    Haematologica; 2011 Apr; 96(4):507-14. PubMed ID: 21228038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic Resonance Liver Iron Concentration Can Guide Venesection Decision-Making in Hyperferritinemia.
    Bhuva M; Patterson I; Godfrey EM; Bowden DJ; Griffiths WJH
    Dig Dis Sci; 2023 Jun; 68(6):2704-2709. PubMed ID: 36929239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.